home / stock / chsyf / chsyf quote
Last: | $0.9307 |
---|---|
Change Percent: | 0.0% |
Open: | $0.9307 |
Close: | $0.9307 |
High: | $0.9307 |
Low: | $0.9307 |
Volume: | 110 |
Last Trade Date Time: | 05/01/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.9307 | $0.9307 | $0.9307 | $0.9307 | $0.9307 | 110 | 05-01-2024 |
$0.9313 | $0 | $0.9313 | $0 | $0 | 10 | 04-30-2024 |
$0.9313 | $0.9313 | $0.9313 | $0.9313 | $0.9313 | 10,980 | 04-05-2024 |
$1.518 | $0 | $1.518 | $0 | $0 | 358,000 | 02-09-2024 |
$1.518 | $0 | $1.518 | $0 | $0 | 3,000 | 01-31-2024 |
$1.518 | $0 | $1.518 | $0 | $0 | 48,000 | 01-10-2024 |
$1.518 | $0 | $1.518 | $0 | $0 | 74,000 | 10-16-2023 |
$1.518 | $0 | $1.518 | $0 | $0 | 59,000 | 08-30-2023 |
$1.518 | $0 | $1.518 | $0 | $0 | 20 | 08-08-2023 |
$1.518 | $0 | $1.518 | $0 | $0 | 20 | 08-01-2023 |
$1.518 | $1.518 | $1.518 | $1.518 | $1.518 | 200 | 07-19-2023 |
$1.46 | $1.46 | $1.46 | $1.46 | $1.46 | 100 | 06-07-2023 |
$1.6 | $1.6 | $1.6 | $1.6 | $1.6 | 1,991 | 04-07-2023 |
$1.6 | $1.6 | $1.6 | $1.6 | $1.6 | 1,991 | 04-06-2023 |
$1.54 | $1.54 | $1.54 | $1.54 | $1.54 | 100 | 03-23-2023 |
$1.381 | $1.381 | $1.381 | $1.381 | $1.381 | 200 | 12-01-2022 |
$1.28 | $1.28 | $1.28 | $1.28 | $1.28 | 667 | 11-01-2022 |
$1.59 | $0 | $1.59 | $0 | $0 | 3,000 | 08-12-2022 |
$1.59 | $1.55 | $1.59 | $1.59 | $1.55 | 2,648 | 04-18-2022 |
$1.62 | $1.62 | $1.62 | $1.62 | $1.62 | 6,700 | 04-04-2022 |
News, Short Squeeze, Breakout and More Instantly...
China Medical Sys Hldgs Company Name:
CHSYF Stock Symbol:
OTCMKTS Market:
SHENZHEN, CHINA, April 23, 2024 (GLOBE NEWSWIRE) -- Desidustat Tablets are novel, oral HIF-PHI for treating anaemia in non-dialysis adult chronic kidney disease patients. The Product is administrated orally, thus expecting to improve the treatment compliance of patients and to meet the unme...
Povorcitinib, a selective oral JAK1 inhibitor discovered by Incyte, is an investigational medicine being evaluated for the treatment of non-segmental vitiligo, hidradenitis suppurativa (HS), prurigo nodularis (PN), asthma and chronic spontaneous urticaria HONG KONG, China and WILMINGTON, De...
SHENZHEN, CHINA, March 27, 2024 (GLOBE NEWSWIRE) -- On March 27, 2024, China Medical System (“CMS” or the “Company”) released its 2023 annual results. The Company recorded a turnover of RMB8,013 million, a year-on-year decrease of 12.4%; in the case that all medicines ...